Literature DB >> 15643105

Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.

Taku Nakagami, Norio Yasui-Furukori, Manabu Saito, Kazuo Mihara, Ronald De Vries, Tsuyoshi Kondo, Sunao Kaneko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15643105     DOI： 10.1097/01.jcp.0000150234.99619.f3

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

1.  Quantitative prediction of cytochrome P450 (CYP) 2D6-mediated drug interactions.

Authors:  Michel Tod; Sylvain Goutelle; Fannie Clavel-Grabit; Grégoire Nicolas; Bruno Charpiat
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

2.  Comparative cytochrome p450 in vitro inhibition by atypical antipsychotic drugs.

Authors:  Guillermo Gervasini; Maria J Caballero; Juan A Carrillo; Julio Benitez
Journal:  ISRN Pharmacol       Date:  2013-02-13

3.  Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.

Authors:  John K Darby; David J Pasta; Michael G Wilson; John Herbert
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 3.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.